Clinical Trial Update: Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating azelaic acid as a novel treatment for Central Centrifugal Cicatricial Alopecia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Centrifugal Cicatricial Alopecia

Drugs mentioned

• Azelaic acid (azelaic acid)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Central Centrifugal Cicatricial Alopecia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING